66th annual meeting società italiana di cancerologia integrating evolution, ecosystems and emerging technologies to transform cancer therapy
Convegno internazionale residenziale (7-9 ott. 2026, Roma) della Società Italiana di Cancerologia per oncologi e ricercatori. Integra biologia evolutiva tumorale, ecosistemi del cancro, AI multimodale, omics spaziale, liquid biopsy, vaccini tumorali e terapie di precisione. Quota: 620 €.
Provider
Meeting SrlMeeting Srl (7194)
Crediti ECM
8,4
Costo
620,00 €
Durata
12 ore
Date
7 - 9 ottobre 2026
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
Razionale scientifico
Cancer is a dynamic and evolving disease. Its initiation, progression, immune escape, and therapy resistance are driven by complex biological, molecular, and ecological forces, creating a constantly shifting landscape that challenges modern oncology. Understanding and intervening in this complexity requires integrating evolutionary biology, tumor ecosystem analysis, and state-of-the-art technologies together with novel approaches of precision oncology. The scientific program of the 66th Annual Meeting of the Italian Cancer Society is designed to reflect this conceptual shift and bring together clinical and preclinical researcher to discuss the most novel and compelling evidences that might help in designing more active and less toxic treatments. The meeting will be therefore of interest for both preclinical and clinical researchers, working in different areas of cancer research. Over three days the scientific program will see the participation of Italian and foreign world-renowned scientist to integrate clinical and preclinical presentations on different pathologies including but not limited to women (breast and gynecological), gastrointestinal, prostate, lung and pancreatic cancers. This meeting brings together evolutionary biology, technology, and clinical innovation to redefine how we understand and treat cancer. We will examine tumor evolution and ecosystems, revealing how microenvironmental pressures shape heterogeneity, immune escape, metastasis, and resistance. We will showcase transformative technologies — multimodal AI, spatial omics, digital twins, liquid biopsies, and advanced imaging — that are reshaping how cancer is mapped, modeled, and predicted, accelerating translation to the clinic. Finally, we will discuss of precision oncology, focusing on adaptive therapies, rational combinations, and biomarker-driven strategies that exploit tumor vulnerabilities uncovered by evolutionary and multi-omic insights. On the opening day SIC will hold an open session dedicated to survivors, patients, caregivers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients' quality of life.
Luogo
Centro Congressi Europa, Università Cattolica
Largo Francesco Vito 1, Roma (RM)
Programma
- 9.30–10.30Registration
- 13.30–14.00Opening Address
- 14.00–14.30Opening Lecture: Evolutionary characterisation of lung cancer metastasisMariam Jamal-Hanjani
- 14.30–16.00Lecture 1: When mistranslation meets cancer immunotherapyReuven Agami
- 15.00–15.15Selected abstract 1
- 15.15–15.30Selected abstract 2
- 15.30–16.00Lecture 2: Integrating multiple dimensions to understand cancer evolutionElisa Oricchio
- 17.00–17.30Coffee Break
- 17.30–19.00The EMBO Keynote Lecture: Metabolic & Epigenetic Control of Cancer ImmunityMassimiliano Mazzone
- 18.00–18.15Selected abstract 3
- 18.15–18.30Selected abstract 4
- 18.30–19.00Lecture 4: Fibroblast remodeling in inflammation and cancerRuth Scherz-Shouval
Responsabili del corso
MEETING SRL
Provider
ID Provider: N° 7194
Città: Udine (UD)
Tipologia: Società, Agenzie Ed Enti Privati
Stato accreditamento: Standard
Carmine Carbone
Responsabile scientifico
Specializzazione: Oncologia medica
Struttura: Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Ruolo: Ricercatore e Medico Oncologo
Con il contributo non vincolante di
- MSD ITALIA
- PIERRE-FABRE
- BRISTOL MYERS SQUIBB
- BAYER
- ASTRAZENECA
Domande frequenti
Questo evento è accreditato per: Medico Chirurgo (Farmacologia E Tossicologia Clinica, Medicina Nucleare); Farmacista (Farmacista Pubblico Del Ssn); Medico Chirurgo (Oncologia, Genetica Medica, Patologia Clinica (Laboratorio Di Analisi Chimico-Cliniche E Microbiologia), Medicina Interna, Chirurgia Generale, Biochimica Clinica, Laboratorio Di Genetica Medica, Radiodiagnostica, Medicina Generale (Medici Di Famiglia), Ematologia, Anatomia Patologica).
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.